Exogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43

Eun Roh, Jae Woo Park, Gil Myoung Kang, Chan Hee Lee, Hong Dugu, So Young Gil, Do Kyeong Song, Hyo Jin Kim, Gi Hoon Son, Rina Yu, Min Seon Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 is an important regulator of hypothalamic neuronal function. Thus, an adequate hypothalamic NAD content is critical for maintaining normal energy homeostasis. Methods: We investigated whether NAD supplementation increases hypothalamic NAD levels and affects energy metabolism in mice. Furthermore, we investigated the mechanisms underlying the effects of exogenous NAD on central metabolism upon entering the hypothalamus. Results: Central and peripheral NAD administration suppressed fasting-induced hyperphagia and weight gain in mice. Extracellular NAD was imported into N1 hypothalamic neuronal cells in a connexin 43-dependent and CD73-independent manner. Consistent with the in vitro data, inhibition of hypothalamic connexin 43 blocked hypothalamic NAD uptake and NAD-induced anorexia. Exogenous NAD suppressed NPY and AgRP transcriptional activity, which was mediated by SIRT1 and FOXO1. Conclusions: Exogenous NAD is effectively transported to the hypothalamus via a connexin 43-dependent mechanism and increases hypothalamic NAD content. Therefore, NAD supplementation is a potential therapeutic method for metabolic disorders characterized by hypothalamic NAD depletion.

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalMetabolism: Clinical and Experimental
Volume88
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Connexin 43
NAD
Energy Metabolism
Hypothalamus
Hyperphagia
Anorexia
Weight Gain

Keywords

  • Connexin 43
  • Energy metabolism
  • Hypothalamus
  • NAD
  • Supplement

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Exogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43. / Roh, Eun; Park, Jae Woo; Kang, Gil Myoung; Lee, Chan Hee; Dugu, Hong; Gil, So Young; Song, Do Kyeong; Kim, Hyo Jin; Son, Gi Hoon; Yu, Rina; Kim, Min Seon.

In: Metabolism: Clinical and Experimental, Vol. 88, 01.11.2018, p. 51-60.

Research output: Contribution to journalArticle

Roh, Eun ; Park, Jae Woo ; Kang, Gil Myoung ; Lee, Chan Hee ; Dugu, Hong ; Gil, So Young ; Song, Do Kyeong ; Kim, Hyo Jin ; Son, Gi Hoon ; Yu, Rina ; Kim, Min Seon. / Exogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43. In: Metabolism: Clinical and Experimental. 2018 ; Vol. 88. pp. 51-60.
@article{f4ee5f81e39b407fae898e544019a204,
title = "Exogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43",
abstract = "Background: Nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 is an important regulator of hypothalamic neuronal function. Thus, an adequate hypothalamic NAD content is critical for maintaining normal energy homeostasis. Methods: We investigated whether NAD supplementation increases hypothalamic NAD levels and affects energy metabolism in mice. Furthermore, we investigated the mechanisms underlying the effects of exogenous NAD on central metabolism upon entering the hypothalamus. Results: Central and peripheral NAD administration suppressed fasting-induced hyperphagia and weight gain in mice. Extracellular NAD was imported into N1 hypothalamic neuronal cells in a connexin 43-dependent and CD73-independent manner. Consistent with the in vitro data, inhibition of hypothalamic connexin 43 blocked hypothalamic NAD uptake and NAD-induced anorexia. Exogenous NAD suppressed NPY and AgRP transcriptional activity, which was mediated by SIRT1 and FOXO1. Conclusions: Exogenous NAD is effectively transported to the hypothalamus via a connexin 43-dependent mechanism and increases hypothalamic NAD content. Therefore, NAD supplementation is a potential therapeutic method for metabolic disorders characterized by hypothalamic NAD depletion.",
keywords = "Connexin 43, Energy metabolism, Hypothalamus, NAD, Supplement",
author = "Eun Roh and Park, {Jae Woo} and Kang, {Gil Myoung} and Lee, {Chan Hee} and Hong Dugu and Gil, {So Young} and Song, {Do Kyeong} and Kim, {Hyo Jin} and Son, {Gi Hoon} and Rina Yu and Kim, {Min Seon}",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.metabol.2018.08.005",
language = "English",
volume = "88",
pages = "51--60",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Exogenous nicotinamide adenine dinucleotide regulates energy metabolism via hypothalamic connexin 43

AU - Roh, Eun

AU - Park, Jae Woo

AU - Kang, Gil Myoung

AU - Lee, Chan Hee

AU - Dugu, Hong

AU - Gil, So Young

AU - Song, Do Kyeong

AU - Kim, Hyo Jin

AU - Son, Gi Hoon

AU - Yu, Rina

AU - Kim, Min Seon

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: Nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 is an important regulator of hypothalamic neuronal function. Thus, an adequate hypothalamic NAD content is critical for maintaining normal energy homeostasis. Methods: We investigated whether NAD supplementation increases hypothalamic NAD levels and affects energy metabolism in mice. Furthermore, we investigated the mechanisms underlying the effects of exogenous NAD on central metabolism upon entering the hypothalamus. Results: Central and peripheral NAD administration suppressed fasting-induced hyperphagia and weight gain in mice. Extracellular NAD was imported into N1 hypothalamic neuronal cells in a connexin 43-dependent and CD73-independent manner. Consistent with the in vitro data, inhibition of hypothalamic connexin 43 blocked hypothalamic NAD uptake and NAD-induced anorexia. Exogenous NAD suppressed NPY and AgRP transcriptional activity, which was mediated by SIRT1 and FOXO1. Conclusions: Exogenous NAD is effectively transported to the hypothalamus via a connexin 43-dependent mechanism and increases hypothalamic NAD content. Therefore, NAD supplementation is a potential therapeutic method for metabolic disorders characterized by hypothalamic NAD depletion.

AB - Background: Nicotinamide adenine dinucleotide (NAD)-dependent deacetylase SIRT1 is an important regulator of hypothalamic neuronal function. Thus, an adequate hypothalamic NAD content is critical for maintaining normal energy homeostasis. Methods: We investigated whether NAD supplementation increases hypothalamic NAD levels and affects energy metabolism in mice. Furthermore, we investigated the mechanisms underlying the effects of exogenous NAD on central metabolism upon entering the hypothalamus. Results: Central and peripheral NAD administration suppressed fasting-induced hyperphagia and weight gain in mice. Extracellular NAD was imported into N1 hypothalamic neuronal cells in a connexin 43-dependent and CD73-independent manner. Consistent with the in vitro data, inhibition of hypothalamic connexin 43 blocked hypothalamic NAD uptake and NAD-induced anorexia. Exogenous NAD suppressed NPY and AgRP transcriptional activity, which was mediated by SIRT1 and FOXO1. Conclusions: Exogenous NAD is effectively transported to the hypothalamus via a connexin 43-dependent mechanism and increases hypothalamic NAD content. Therefore, NAD supplementation is a potential therapeutic method for metabolic disorders characterized by hypothalamic NAD depletion.

KW - Connexin 43

KW - Energy metabolism

KW - Hypothalamus

KW - NAD

KW - Supplement

UR - http://www.scopus.com/inward/record.url?scp=85053759707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053759707&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2018.08.005

DO - 10.1016/j.metabol.2018.08.005

M3 - Article

VL - 88

SP - 51

EP - 60

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

ER -